LIMホメオドメイン因子Lhx3とLhx4は,モーターニューロンのサブタイプアイデンティティを割り当てます
K Sharma1, H Z Sheng, K Lettieri
1Gene Expression Laboratory, The Salk Institute, La Jolla, California 92037, USA.
Cell
|December 29, 1998
まとめ
LIMホメオドメイン因子Lhx3とLhx4は,モーターニューロン軸索の軌道を指定する. これらの要因は,運動ニューロンの軸が発達中に神経管から腹側または背側で成長するかどうかを一時的に制御します.
科学分野:
- 神経科学は神経科学である.
- 発達生物学 発達生物学について
- 遺伝学 遺伝学とは
背景:
- モーターニューロンのサブクラスは,動きを制御する.
- モーターニューロン軸索の軌道を特定する発達メカニズムは完全に理解されていません.
研究 の 目的:
- モーターニューロンサブクラスの特異化におけるLIMホメオドメイン因子Lhx3およびLhx4の役割を調査する.
- これらの要因が軸軸投射方向にどのように影響するか判断する.
主な方法:
- Lhx3およびLhx4欠陥胚におけるモーターニューロン発達の分析.
- 背面発出モーターニューロンにおけるLhx3の誤表現の研究.
主要な成果:
- Lhx3とLhx4は,内側から出る運動ニューロン (v-MN) で一時的に発現します.
- Lhx3/Lhx4の欠如により,v-MNは背面から出る運動ニューロン (d-MN) の同一性を採用する.
- d-MNにおけるLhx3の誤表現は,その軸索を腹部方向に方向転換させます.
結論:
- Lhx3 と Lhx4 はバイナリで作用し,モーターアクソン軌道を指定します.
- これらの要因は,重要な発達窓の間,v-MNおよびd-MNサブクラスを定義します.
関連する概念動画
Pleiotropy
31.3K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.3K
Master Transcription Regulators
6.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
The Ratio of X Chromosome to Autosomes
11.6K
In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female...
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female...
11.6K
General Transcription Factors
5.9K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.9K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Methods of Nuclear Reprogramming
1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K


